ASLAN Pharmaceuticals and IQVIA Biotech Enter Into Strategic Collaboration

ASLAN Pharmaceuticals and IQVIA Biotech Enter Into Strategic Collaboration
MENLO PARK, Calif. and SINGAPORE, Dec. 06, 2021 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals Pte Ltd (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the appointment of IQVIA , a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, as its preferred clinical research organization for logistics related to decentralized clinical trials, including the global oversight, expansion and engagement of patients for trials related to the clinical development of ASLAN004 and ASLAN003.
IQVIA Biotech will provide …

Read the source article at biospace.com
2021-12-06 02:00:00